US NCI to overhaul NCI-60 tumour cell lines

On February 24, 2016 a panel of 60 human cancer cell lines grown in culture to be retired in favour of patient-derived tumour xenografts. Following a special conference organised by the American Association for Cancer Research (AACR) Heidi Ledford wrote, that after more than 25 years of heavy use by researchers around the world, the US National Cancer Institute (NCI) has decided to retire the NCI-60, its panel of 60 human cancer cell lines grown in culture. Read more here.